289 related articles for article (PubMed ID: 19714494)
1. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
Akaike A; Takada-Takatori Y; Kume T; Izumi Y
J Mol Neurosci; 2010 Jan; 40(1-2):211-6. PubMed ID: 19714494
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade.
Takada-Takatori Y; Kume T; Sugimoto M; Katsuki H; Sugimoto H; Akaike A
Neuropharmacology; 2006 Sep; 51(3):474-86. PubMed ID: 16762377
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
Takatori Y
Yakugaku Zasshi; 2006 Aug; 126(8):607-16. PubMed ID: 16880719
[TBL] [Abstract][Full Text] [Related]
4. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Arias E; Gallego-Sandín S; Villarroya M; García AG; López MG
J Pharmacol Exp Ther; 2005 Dec; 315(3):1346-53. PubMed ID: 16144975
[TBL] [Abstract][Full Text] [Related]
5. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
Takada Y; Yonezawa A; Kume T; Katsuki H; Kaneko S; Sugimoto H; Akaike A
J Pharmacol Exp Ther; 2003 Aug; 306(2):772-7. PubMed ID: 12734391
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
[TBL] [Abstract][Full Text] [Related]
7. Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation.
Takada-Takatori Y; Kume T; Izumi Y; Ohgi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
Biol Pharm Bull; 2009 Mar; 32(3):318-24. PubMed ID: 19252271
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
Noh MY; Koh SH; Kim Y; Kim HY; Cho GW; Kim SH
J Neurochem; 2009 Mar; 108(5):1116-25. PubMed ID: 19077054
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors.
Shen H; Kihara T; Hongo H; Wu X; Kem WR; Shimohama S; Akaike A; Niidome T; Sugimoto H
Br J Pharmacol; 2010 Sep; 161(1):127-39. PubMed ID: 20718745
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection of rat retinal ganglion cells mediated through alpha7 nicotinic acetylcholine receptors.
Iwamoto K; Mata D; Linn DM; Linn CL
Neuroscience; 2013 May; 237():184-98. PubMed ID: 23402849
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
Kume T; Sugimoto M; Takada Y; Yamaguchi T; Yonezawa A; Katsuki H; Sugimoto H; Akaike A
Eur J Pharmacol; 2005 Dec; 527(1-3):77-85. PubMed ID: 16313899
[TBL] [Abstract][Full Text] [Related]
12. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
Kihara T; Sawada H; Nakamizo T; Kanki R; Yamashita H; Maelicke A; Shimohama S
Biochem Biophys Res Commun; 2004 Dec; 325(3):976-82. PubMed ID: 15541385
[TBL] [Abstract][Full Text] [Related]
13. Astrocytic α7 Nicotinic Receptor Activation Inhibits Amyloid-β Aggregation by Upregulating Endogenous αB-crystallin through the PI3K/Akt Signaling Pathway.
Ren Z; Yang M; Guan Z; Yu W
Curr Alzheimer Res; 2019; 16(1):39-48. PubMed ID: 30345917
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation.
Tyagi E; Agrawal R; Nath C; Shukla R
Neurochem Int; 2010 Jan; 56(1):135-42. PubMed ID: 19781587
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries.
Laudenbach V; Medja F; Zoli M; Rossi FM; Evrard P; Changeux JP; Gressens P
FASEB J; 2002 Mar; 16(3):423-5. PubMed ID: 11790724
[TBL] [Abstract][Full Text] [Related]
17. Activation of α7-nAChRs protects SH-SY5Y cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death via ERK/p53 signaling pathway.
Xu S; Yang B; Tao T; Zhang J; Liu Y; Hu J; Fan Y; Zhang G
J Cell Physiol; 2019 Aug; 234(10):18480-18491. PubMed ID: 30912145
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.
Shimohama S
Biol Pharm Bull; 2009 Mar; 32(3):332-6. PubMed ID: 19252273
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
